Apollon Wealth Management LLC Acquires 4,076 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Apollon Wealth Management LLC grew its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 14.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,708 shares of the company’s stock after acquiring an additional 4,076 shares during the quarter. Apollon Wealth Management LLC owned 0.50% of VanEck Pharmaceutical ETF worth $2,822,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in PPH. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management increased its holdings in VanEck Pharmaceutical ETF by 117.4% in the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after purchasing an additional 108,000 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of VanEck Pharmaceutical ETF by 51.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after purchasing an additional 84,273 shares during the last quarter. Adamsbrown Wealth Consultants LLC increased its stake in shares of VanEck Pharmaceutical ETF by 102.3% in the fourth quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock valued at $12,910,000 after buying an additional 75,659 shares during the period. Thrivent Financial for Lutherans raised its holdings in VanEck Pharmaceutical ETF by 33.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock valued at $22,322,000 after buying an additional 59,025 shares during the last quarter. Finally, Miller Investment Management LP boosted its position in VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after buying an additional 24,446 shares during the period.

VanEck Pharmaceutical ETF Price Performance

PPH opened at $89.40 on Monday. The company’s 50 day moving average price is $87.76 and its two-hundred day moving average price is $91.72. The firm has a market capitalization of $557.86 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a fifty-two week low of $84.48 and a fifty-two week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were issued a $0.411 dividend. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.